Akumin Inc

Akumin — Q3 2019 Earnings Presentation

10 slides from Akumin's earnings presentation, November 2019

  1. Slide 1: Q3 2019 Financial Results

    Q3 2019 FINANCIAL RESULTS TSX: AKU.U (US$) / AKU (C$)

  2. Slide 2: Forward-looking Information Disclaimer

    Forward-looking Information This report contains or incorporates by reference “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian securities laws. Disclaimer Forward-looking statements describe our future plans, strategies, expectations and objecti

  3. Slide 3: Executive Summary Consolidated Financial Results

    Executive Summary Consolidated Financial Results (in thousands, except for per share amounts) Summary Q3 2019 Q3 2018 YTD 2019 YTD 2018 Akumin continues RVUs 1,435 850 3,664 2,271 to see robust growth Revenue 68,874 39,131 170,410 109,331 across key metrics EBITDA 19,323 4,278 42,612 14,168 Adjusted

  4. Slide 4: Volume: Relative Value Units (RVUs)

    Relative Value Units (RVUs) (Values in thousands) Volume Strong broad-based 1,435 volume growth across all markets 1,163 Akumin achieved 1,066 1,020 record volume growth in Q3 2019: 850 1 0% same-center growth 9% year-over-year 6 volume growth Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 4 PRESENTATION B

  5. Slide 5: Revenue

    Revenue (Values in USD thousands) Revenue $68,874 Volume growth and stable pricing driving $53,985 6% year-over-year 7 higher revenue $47,551 revenue growth $45,452 $39,131 elatively stable R pricing environment with higher proportion of revenue mix from attorney/auto/payors Q3 2018 Q4 2018 Q1 2019

  6. Slide 6: Adjusted EBITDA

    Adjusted EBITDA (Values in USD thousands) Adjusted EBITDA $18,039 Improving margin profile resulting from $12,290 The Company remains focused on integrating revenue acceleration and previous acquisitions and integration efficiencies $9,200 $9,251 $8,285 continues to pursue cost- reduction opportunit

  7. Slide 7: Balance Sheet

    Day Sales DSO is 98 days (Q2 2019 – 92 days) Balance Sheet Outstanding DSO is 77 days excluding auto/attorney payors (Q2 2019 – 69 days) As at September 30, 2019 (DSO) (1) The increase in DSO is a result of: — Strong organic growth and higher proportion of revenue mix from attorney/auto payors with

  8. Slide 8: Operational Highlights

    Operational 1 n August 16, 2019, completed acquisition of five imaging O centers in El Paso, Texas (“El Paso Acquisition”) Highlights urchase price of $11 mm (financed with Company’s P senior credit facility) Akumin continues to Expect to add annual revenue of approximately $13 mm(1) identify opport

  9. Slide 9: Strategic Update

    Strategic 1 uilding density in core geographic markets B Update 2 ebranding initiatives are on-going R Akumin remains 3 treamlining revenue cycle to improve DSO S focused on its key strategic priorities 4 ocusing on integrating previous acquisitions F and pursuing cost-reduction opportunities 5 ngag

  10. Slide 10: Question & Answer

    QUESTION & ANSWER TSX: AKU.U (US$) / AKU (C$)

Akumin — Q3 2019 Earnings Presentation on 6ix